How do I find a fractional CRO for a biotech company?

Direct Answer

Finding a fractional CRO for a biotech company in 2027 requires a targeted approach that blends deep domain knowledge (e.g., FDA regulatory pathways, KOL engagement) with modern RevOps capabilities like AI-driven pipeline scoring and multi-stakeholder buying committee management. Start by vetting candidates who have held VP-level or above revenue roles at biotech firms with similar stage (pre-revenue, Series A/B, or commercial stage) and therapeutic area focus. Use specialized networks (e.g., Biotech CRO Network, LifeSci Search) and platforms like LinkedIn Sales Navigator to filter for fractional experience, then assess their ability to leverage Salesforce and Gong for deal intelligence in longer sales cycles (12–18 months typical). Avoid generalist CROs; the right hire will demonstrate a track record of compressing time-to-close in regulated markets and aligning revenue operations with MEDDPICC frameworks for complex buying committees.

Why a Fractional CRO for Biotech in 2027?

The 2027 RevOps reality is defined by AI in the funnel, vendor consolidation, and longer enterprise sales cycles (average 14–18 months for biotech diagnostics/therapeutics). For biotech startups and mid-stage firms, a full-time CRO (costing $250k–$400k+ total comp) is often premature. A fractional CRO (typically 20–40 hours/week, $5k–$15k/month) provides:

• Regulatory fluency: Understanding of FDA clearance cycles, HIPAA compliance, and KOL (Key Opinion Leader) engagement.
• AI-ready playbooks: Ability to deploy Clari or Gong for real-time deal risk scoring across 8–12 member buying committees.
• Capital efficiency: Variable cost aligned to revenue milestones (e.g., first $1M ARR, Series B raise).

Step 1: Define Your Biotech-Specific Requirements

Before searching, document your revenue maturity and market context. Use this decision tree to determine if a fractional CRO is right:

Key requirements to list:

• Therapeutic area: Oncology, rare disease, CNS, or diagnostics—each has unique KOL networks and regulatory hurdles.
• Sales cycle length: If your product requires FDA 510(k) or PMA, expect 12–18 month cycles; your CRO must have managed such timelines.
• Buying committee size: Biotech purchasing often involves 8–12 stakeholders (PI, lab director, procurement, legal, compliance). Verify candidate experience with Challenger Sale or MEDDPICC to navigate this.
• AI stack: Expect them to use Gong for call intelligence, Clari for forecasting, and Salesforce for pipeline management.

Step 2: Where to Find Fractional CROs for Biotech

Avoid generic platforms like Upwork. Use these targeted channels:

Specialized Recruiters & Networks

• Biotech CRO Network (biotechcronetwork.com): A curated list of fractional revenue leaders with FDA/regulatory experience.
• LifeSci Search (lifscisearch.com): Recruits for life sciences executive roles, including fractional.
• SaaStr (saastr.com) community: While primarily SaaS, many biotech CROs post in their "Fractional Execs" Slack channel.
• LinkedIn Sales Navigator: Search for "fractional CRO biotech" or "interim VP Sales biotech". Filter by past roles at companies like Illumina, Thermo Fisher, Roche Diagnostics, or Guardant Health.

AI-Powered Matching Platforms

• HiredFractional (hiredfractional.com): Uses AI to match fractional execs to industry-specific needs; filter for "life sciences".
• Toptal (toptal.com): While general, you can request biotech-specific fractional CROs with a vetting process.


Reach Kory White, Fractional CRO: 📅 Book a Quick Call · 💼 Kory on LinkedIn · 🏢 CRO Syndicate

Step 3: Vetting the Fractional CRO

Your vetting must go beyond generic sales metrics. Use this process:

Critical questions to ask:

• "Walk me through a biotech deal where the buying committee had 10+ stakeholders. How did you use MEDDPICC to identify the champion and blocker?" (Look for specific examples with named roles like "PI" or "Lab Director".)
• "How do you use Gong to detect deal risk in a 14-month cycle?" (Expect mention of sentiment analysis, objection tracking, and AI-generated next steps.)
• "What's your experience with FDA regulatory milestones impacting revenue forecasting?" (They should mention Clari or Salesforce forecasts adjusted for FDA decision dates.)
• "How do you align RevOps with clinical trial timelines?" (Expect them to discuss Gong data feeding into Clari for pipeline health.)

Step 4: Compensation & Engagement Model

Fractional CROs in biotech command a premium over generalist fractional roles. In 2027, expect:

• Monthly retainer: $8k–$15k for 20–30 hours/week (higher for rare disease or oncology).
• Equity: 0.5%–1.5% of company equity, vesting over 2 years, tied to revenue milestones (e.g., first $2M ARR).
• Performance bonuses: 10%–20% of base retainer for hitting quarterly pipeline or close targets.
• Contract structure: 3-month trial period, then month-to-month with 30-day notice.

Vendor consolidation note: Many fractional CROs now bundle Salesforce admin, Gong setup, and Clari forecasting into their retainer, reducing the need for separate RevOps hires.

Step 5: Onboarding & Integration with RevOps

Your fractional CRO must integrate into your existing RevOps stack within 2 weeks. Key actions:

• Week 1: Map your Salesforce instance to MEDDPICC fields (e.g., "Economic Buyer", "Champion", "Regulatory Milestone").
• Week 2: Set up Gong call tracking with AI scoring for deal risk (e.g., "Objection Frequency", "Stakeholder Engagement").
• Week 3: Implement Clari for AI-driven forecasting, incorporating FDA timeline data.
• Week 4: Conduct a "buying committee audit" using Gong transcripts to identify missing stakeholders.

AI in the funnel: In 2027, your fractional CRO should use Gong's AI to auto-flag deals where the champion hasn't spoken in 30+ days, or where legal objections are rising. They should also leverage Clari's Copilot to generate weekly pipeline summaries for the board.

FAQ

What is the typical cost of a fractional CRO for a biotech startup? Retainers range from $8k to $15k per month for 20–30 hours/week, plus 0.5%–1.5% equity. For pre-revenue biotech, expect lower retainer ($5k–$8k) but higher equity (1%–2%).

How do I verify a fractional CRO's biotech experience? Ask for 3 references from biotech companies at similar stage. Request a case study of a deal involving FDA regulatory milestones (e.g., 510(k) clearance). Check their LinkedIn for past roles at Illumina, Thermo Fisher, Guardant Health, or Moderna.

Can a fractional CRO work with a part-time RevOps team? Yes, but they must align on Salesforce governance and Gong data quality. Many fractional CROs now include RevOps oversight in their retainer, so you may not need a separate RevOps hire.

What tools should my fractional CRO be proficient with in 2027? Mandatory: Salesforce, Gong, Clari, MEDDPICC framework. Nice-to-have: Outreach or Salesloft for sequencing, Challenger Sale methodology.

How long does it take to see ROI from a fractional CRO? Biotech cycles are long (12–18 months). Expect pipeline improvement in 3–6 months (e.g., 20% more qualified leads), but revenue impact at 9–12 months. Track leading indicators like "time to first KOL meeting" and "buying committee completeness".

What if I need a full-time CRO later? Structure the fractional contract with a 30-day conversion clause. Many fractional CROs will convert to full-time after 6–12 months if the company hits revenue milestones. Include a "right of first refusal" in the contract.

Sources

• Gartner: The Future of Sales in 2027
• Forrester: The State of Revenue Operations, 2026
• McKinsey: Biotech Commercial Models in the AI Era
• Gong Labs: Buying Committee Dynamics in Enterprise Sales
• SaaStr: Fractional Executives: The New Normal for Startups
• Bessemer Venture Partners: The 2027 Cloud Revenue Playbook
• Salesforce: Biotech Sales Playbook for Longer Cycles
• Clari: AI-Driven Forecasting for Life Sciences

Bottom Line

Finding a fractional CRO for biotech requires a laser focus on therapeutic area expertise, buying committee navigation, and AI tool proficiency (Salesforce, Gong, Clari). Use specialized networks, vet for MEDDPICC and regulatory fluency, and structure a performance-based contract with equity. In 2027, the right fractional CRO can compress your revenue timeline by 20–30% while keeping costs variable.

*How to find a fractional CRO for a biotech company in 2027: a RevOps-driven guide to vetting, compensation, and onboarding.*

People also search for: fractional cro biotech company · hire a fractional cro for biotech company · biotech company fractional cro · fractional cro near me